Identifying predictors of equitable gender representation among hematology and oncology fellowship programs.

Authors

null

Sasirekha Pandravada

Advocate Lutheran General Hospital, Park Ridge, IL

Sasirekha Pandravada , Praneet Mylavarapu , Jacob D. Bitran

Organizations

Advocate Lutheran General Hospital, Park Ridge, IL, University of California San Diego Medical Center, San Diego, CA

Research Funding

No funding received

Background: While gender disparities have largely been bridged among hematology and oncology fellows at the national level, there exist many individual fellowship programs that still have marked gender disparity. Our study is the first to examine gender differences among fellows at an institutional level in order to model characteristics of hematology and oncology programs that lead to more equitable gender representation. Methods: For each of the 148 hematology or oncology fellowship programs listed in the Fellowship and Residency Electronic Interactive Database, we collected data on gender, faculty academic rank, and fellow postgraduate year as listed on individual program websites. Further, a program was identified as an academic center if it had an affiliated medical school. Zip code data was used to identify geographic region, local population density, and racial diversity of each program’s surrounding neighborhood. Multiple linear regression was used to model which factors contributed to a program having a higher percentage of female fellows. Results: 3600 faculty and 1488 fellows were included in the analysis. While women were well represented nationally among fellows (46.4%), 52.4% of fellowship programs had fewer than 50% women, and 28.6% of programs had fewer than 35% women. An individual program was more likely to have more female fellows if it had a higher percentage of female assistant professors (p<0.01), associate professors (p<0.01), assistant professors overall (p<0.01), a female program director (PD) or associate program director (APD) (p=0.02), and a designation as an academic center (p<0.01). Notably, the percentage of female full professors had no significant impact (p=0.11) on whether a program was likely to have more female fellows. Conclusions: While women are well represented nationally among hematology and oncology fellows, nearly one in three fellowship programs still have significant gender disparity. Our multivariate model identified several significant factors that predict whether a program was likely to have gender parity among fellows: a higher percentage of female assistant professors, associate professors, assistant professors overall, a female PD or APD, and a designation as an academic center. Whether these factors together highlight the importance of accessible mentorship or direct female faculty role models requires further study. However, by beginning to identify these significant factors, we hope to aid fellowship programs focus efforts when trying to achieve equitable gender representation.

Gender representation among hematology and oncology fellows and faculty.

Fellow (PGY4-PGY6)
Assistant Professor
Associate Professor
Full Professor
Program Director
% Female
46.4%
51.1%
44.8%
25.1%
48.6%
% Programs with <50% Female
52.4%
41.0%
58.1%
89.5%
-
% Programs with <35% Female
28.6%
18.1%
31.4%
75.2%
-

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Professional Development and Education Advances

Track

Medical Education and Professional Development

Sub Track

Workplace Disparities/Issues

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 11055)

DOI

10.1200/JCO.2022.40.16_suppl.11055

Abstract #

11055

Poster Bd #

246

Abstract Disclosures

Similar Abstracts

First Author: Shruti Rajesh Patel

First Author: Leen Mohammad Al-Kraimeen

Abstract

2021 ASCO Annual Meeting

Self-reported gender bias encountered by hematology and oncology fellows.

First Author: Nino Balanchivadze